MYLK and colorectal cancer: Analysis of data from TCGA showed a significant difference in MLCK1 expression between normal and colorectal cancer patients (p < 0.01) (Fig. 1b), but no significant correlation with overall survival (OS) (Fig. 1c) and disease-free survival (DFS) (Fig. 1d).